Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-08-101882
Filing Date
2008-05-05
Accepted
2008-05-05 12:54:10
Documents
3
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A d10ka.htm 10-K/A 290495
2 CERTIFICATION OF CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 2676
3 CERTIFICATION OF CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 2737
  Complete submission text file 0001193125-08-101882.txt   297424
Mailing Address 11755 WILSHIRE BLVD., 20TH FLOOR LOS ANGELES CA 90025
Business Address 11755 WILSHIRE BLVD., 20TH FLOOR LOS ANGELES CA 90025 310-883-1300
Abraxis Biosciences, Inc. (Filer) CIK: 0001409012 (see all company filings)

EIN.: 300431735 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33657 | Film No.: 08801579
SIC: 2834 Pharmaceutical Preparations